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INTRODUCTION
Acute pyelonephritis (APN) is a serious form of urinary tract
infection (UTI). Its annual incidence is 250,000 cases in the
US and the incidence of hospitalized APN is 11.7 cases per
10,000 population among females and 2.4 cases per 10,000
population among males (1). While in Korea, the incidence
rate is 35.7 cases per 10,000 population (2). Clinical mani-
festations include severe systemic symptoms such as high
fever, chilling, nausea and vomiting. Without proper treat-
ments, the renal pelvis and its parenchyme can be damaged,
possible following sepsis that may lead to death. In the cases
with associated sepsis, the mortality reaches 10-20% (3, 4).
In Korea, the high mortality (2.1 cases per 1,000 persons
among hospitalized patients) has been reported (2).
Key consideration in the treatment of APN is to under-
stand the current characteristics of the current community,
causative bacterial spectrum, and antibiotic resistance pat-
terns. Antibiotic resistance is on the gradual increase, and
ampicillin and trimethoprim/sulfamethoxazole (TMP/SMX)
that have been the first-line antibiotics could not show effec-
tive sensitivity any longer (5). And at the early phase of the
treatment for APN when the isolation of causative microor-
ganisms is not performed yet, antibiotics should be admin-
istered empirically. It is required to understand accurately
the presently most frequent causative microorganisms and
antibiotic resistance. In addition, as the westernized life style
and eating habit are accelerating prevalence of diabetes and
other chronic diseases as well as Korean society is getting more
aged, the alteration of the epidemiology of APN is anticipat-
ed, with its epidemic examination at regular basis. 
The cases with underlying causes are referred to as compli-
cated APN, and its proportion is 21.1-37.8% (1-4). Although
APN could be treated readily with appropriate antibiotics,
hydration, and bed rest, complicated APN should be done
with correcting its cause. Moreover, it has been reported that
complicated APN shows high positive rate with blood cul-
ture and more sever clinical symptoms than those of simple
APN (5, 6). 
Therefore, we examined the current clinical characteris-
tics and the necessity of surgical treatment in 1,026 cases of
APN patients for the past 5 yr.
MATERIALS AND METHODS
On 1,026 patients who were admitted to Kyung Hee Uni-
versity Medical Center under the diagnosis of APN from
January 2000 to December 2004, we retrospectively exam-
ined clinical symptoms, causes, causative microorganisms,
antibiotic sensitivities, and curative urological procedures
by reviewing their medical records. 
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Acute Pyelonephritis: Clinical Characteristics and the Role of the 
Surgical Treatment
The epidemiology of acute pyelonephritis (APN) has changed with time. Therefore
we investigated the current clinical characteristics of APN and the significance of
proper surgical management for treatment of 1,026 APN patients in South Korea
for the past 5 yr. The male-to-female ratio was about 1:8. The peak ages of female
patients were 20s (21.3%) and over 60s (23.7%), while that of male was over 60s
(38.1%). The occurrence of sepsis was 10.1%. Complicated APN patients were
35.4%. Ninety-four patients (9.2%) needed urological procedures. The duration of
the flank pain and of the costovertebral angle tenderness in complicated APN patients
was statistically significantly longer than that with simple APN patients (4.3 vs. 3.4
days, 4.4 vs. 4.0 days). If flank pain and costovertebral angle tenderness sustain
over 4 days, proper radiologic studies should be performed immediately with the
consideration of surgical procedure. Also the resistance to antibiotics was increas-
ing. As the sensitivities to ampicillin (27.2%) and trimethoprim/sulfamethoxazole
(44.7%) of Escherichia coli and Klebsiella pneumoniae were very low, it is neces-
sary to take the careful choice of antibiotics into consideration.
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In addition to the clinical diagnosis, patients were required
to meet more than 3 of the following 5 criteria: 1) clinical
symptoms of APN (chilling, nausea, vomiting, flank pain);
2) costovertebral angle tenderness; 3) leukocytosis (higher
than 10,000/μ L); 4) fever (higher than 38.5℃); 5) white blood
cell (WBC) count ≥5 cells per high-power field on centri-
fuged urine sediment or more 100,000 CFU/mL microor-
garnisms in urine culture (7).
Infected site (right, left, and both) was localized with clin-
ical symptoms such as flank pain and costovertebral angle
tenderness. In cases which clinical symptoms were vague,
we judged the localization by radiologic findings.
The urine collecting methods for males were that lift the
prepuce, wash the urethral meatus with 2% boric sponge,
and collect the mid stream urine in a sterile plastic cup with
a lid, and in female cases, in the lithotomy position, wash the
perineum and the urethral meatus by the identical method,
and collect the mid stream urine was using a nelaton catheter.
The collected urine was inoculated to blood agar broth and
MacConkey broth, 0.001 mL each, cultured in a 37℃ incu-
bator for 24 hr, and the number of bacterial colony per 1 mL
urine was calculated. The blood was also inoculated to blood
agar broth and MacConkey broth, cultured for 5 days, and
the growth of bacteria was assessed. 
The identification of bacteria and antibiotic sensitivity were
assessed by the disk diffusion test described by the National
Commitee for Clinical Laboratory Standards. Clinical symp-
toms, sign, and the presence of lower urinary tract symptoms
were assessed, and the duration of the fever higher than 38.5℃,
the duration of the flank pain, and the duration of the cos-
tovertebral angle tenderness were assessed. 
To diagnosis complicated APN, we examined the presence
of following diseases: structural and functional abnormalities
(urinary tract stone disease, neurogenic bladder, vesicoureter-
al reflux (VUR), obstructive uropathy, prostate disease); uro-
logic manipulation (cystoscopic or ureteroscopic examina-
tion, indwelling catheter, kindey transplantation); the under-
lying diseases which contribute to the persistence of infec-
tion or suppression of immune system (diabetes, immuno-
suppressive state, cystic renal disease). 
As statistics, comparison of continuous variables between
independent two groups was performed by t-test, compari-
son of the frequency was analyzed by Pearson chi-square test,
and the criterion of the determination of significance was
p<0.05.
RESULTS
Patient characteristics
Among total 1,026 cases, male was 118 cases, female were
908 cases, and the ratio of male to female was 1:7.7. The mean
age was 45.5±17.8 yr, male was 49.0±19.2 yr, female was
45.0±17.5 yr, and a difference between genders was not
detected (p>0.05). In males, group of over 60 was 38.1%,
which was the most prevalent age group, and in females,
groups of 20s and over 60s was 21.3% and 23.7%, respec-
tively, which were most prevalent. Particularly, females in
their 20s and 30s were 38.6% of the entire female patients.
Clinical presentation
In regard to the invaded sites, the right kidney was 56.3%,
the left kidney was 32.9%, both kidneys was 10.7%, and a
statistic difference between gender was not detected. The
duration of fever, the duration of the flank pain, and the dura-
tion of the costovertebral angle tenderness was 3.1 days, 3.7
days, and 4.2 days, respectively.
Complicating factors
32.7% of total APN (335 cases, 73 men, 262 women) were
complicated APN. Also 61.9% of total men and 28.9% of
total women were complicated APN, respectively. Among
the complicated APN, the cases with structural and func-
tional abnormality were 214 patients (63.9%), the cases with
underlying medical diseases were 106 patients (37.9%), and
the cases caused by the urologic manipulation were 8 cases
(2.4%). As a single disease, diabetes mellitus (DM) was for
98 cases (29.3%), which was most prevalent, followed by the
order of urolithiasis, vesicoureteral reflux, neurogenic blad-
der, immunosuppressive state, duplicated ureter, ureteral stric-
ture, and so on. Particularly, in the entire male patients, the
portion of complicated APN was 61.9%, and the causality
was in the order of urolithiasis, benign prostate hyperplasia,
DM, and neurogenic bladder (Table 1). In complicated APN,
Female (%)
(n=262)
Male (%)
(n=73)
Total (%)
(n=335)
Disorder of structure or function
Urinary stone disease 22 (30.1) 70 (43.2) 92 (27.5)
Vesicoureteral reflux 7 (9.6) 33 (20.4) 40 (11.9)
Neurogenic bladder 9 (12.3) 26 (16.0) 35 (10.4)
Ureteral obstruction  2 (2.7) 20 (12.3) 22 (6.7)
Duplicated ureter 2 (2.7) 11 (6.8) 13 (3.9)
Benign prostatic hyperplasia 12 (16.4) 0 (0.0) 12 (3.6)
Underlying systemic disease*
Diabetes mellitus 10 (13.7) 88 (54.3) 98 (29.3)
Immunosuppression 6 (8.2) 9 (5.6) 15 (4.5)
Cystic renal disease 2 (2.7) 5 (3.1) 7 (2.1)
Renal failure 3 (4.1) 4 (2.5) 7 (2.1)
Urological manuplation 6 (8.2) 2 (1.2) 8 (2.4)
Others 0 (0.0) 8 (4.9) 8 (2.4)
Patients received urologic  23 (31.5) 71 (27.1) 94 (28.6)
procedure
Table 1. Underlying disease of complicated acute pyelonephritis
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the duration of the flank pain and the costovertebral angle
tenderness was statistically significantly longer than in sim-
ple APN and the portion of male against female (F:M=1:3.6)
was higher than that of simple APN (1:1.14). However, age,
duration of fever, and urine culture positive rate between gen-
ders were not different, respectively (Table 2).
Radiologic findings
Abdominopelvis ultrasonography was performed on 788
cases (76.8%), and among them, 428 cases (54.3%) showed
normal findings, and in the cases showing abnormalities, the
abnormal findings were detected in the order of nephrome-
galy (18.8%), hydronephrosis (12.1%), renal stone (4.2%),
renal cyst (2.9%), and ureter stone (2.1%). 
Bacterial culture and antibiotic sensitivity
The cases that bacteria were isolated by urine culture were
504 patients (49.1%) and the positive culture rate in males
and females was 44.9% and 49.7%, respectively. In regard
to isolated bacteria, Escherichia coli was 84.3%, which was
most prevalent, followed by the order of Klebsiella pneumoni-
ae, Pseudomonas aerusinosa, Enterococcus species, Proteus mirabilis,
Staphylococcus aureus, and Coagulase negative Staphylococcus. In
both males and females, E. coli was the major causative bac-
teria (71.7% vs. 86.0%), and the portion of Pseudomonas aerusi-
nosa was higher in males than in females (18.9% vs. 0.7%)
(Table 3). The cases that bacteria were isolated by blood cul-
ture were 104 patients, which was 10.1% of the entire pa-
tients. Similarly, E. coli was detected to be high, 89.4%, fol-
lowed by the order of Klebsiella pneumoniae, Pseudomonas aeru-
sinosa, and Staphylococcus aureus (Table 3). But each infection
has no difference against the rate of sepsis in this study. In
the cases that microorganisms were isolated in the blood cul-
ture, the duration of the flank pain was significantly longer
than negative cases (4.67 days vs. 3.67 days) (p<0.05). None
of the duration of fever, the duration of the flank pain, the
duration of the costovertebral angle tenderness according to
the isolated microorganisms were statistically different (p>
0.05).
The antibiotic sensitivity test of E. coli were 27.2%, 77.1%,
92.1%, 77.1%, 83.7%, 79.0%, 67.4%, and 44.7% to am-
picillin, ampicillin/sulbactam, amikacin, gentamicin, tob-
ramycin, ciprofloxacin, levofloxcin, and TMP/SMX each.
On the other hand, the mean rates of sensitivity of K. pneu-
monia were 43.2%, 63.5%, 98.1%, 97.2%, 97.3%, 88.3%,
66.7%, and 85.6% to ampicillin, ampicillin/sulbactam, ami-
kacin, gentamicin, tobramycin, ciprofloxacin, levofloxcin, Complicated
APN
Parameter Uncomplicated
APN
Age (yr) 50.0±17.3 43.2±17.6
Sex (M:F) 1:3.6* 1:14.4*
Defervescence (days) 3.1 3.0
Duration of flank pain (days) 4.3* 3.4*
Duration of CVAT (days) 4.4* 4.0*
Positive urine culture (%) 57.6 45.6
Causative organisms (%)
Escherichia coli 79.5 86.8
Klebsiella pneumoniae 5.1 5.8
Proteus mirabilis 2.6 0.8
Pseudomonas aerusinosa 5.1* 0.6*
Table 2. Comparison between the clinical features of compli-
cated and uncomplicated APN
Comparison between complicated APN and uncomplicated APN (*p<
0.05).
APN, acute pyelonephritis; CVAT, costovertebral angle tenderness.
Blood 
culture (%)
(n=104)
Total (%)
(n=505)
Female (%)
(n=452)
Male (%)
(n=53)
Parameter
Escherichia coli 38 (71.7)  388 (86.0) 426 (84.3) 93 (89.4) 
Klebsiella pneumoniae 1 (1.9) 28 (6.2) 29 (5.8) 6 (5.8)
Pseudomonas aerusinosa 10 (18.9) 3 (0.7) 13 (2.6) 3 (2.9)
Enterococcus species 1 (1.9) 9 (2.0) 10 (2.0) 0 (0.0)
Proteus mirabilis 2 (3.8) 7 (1.6) 9 (1.8) 0 (0.0)
Staphylococcus aureus 1 (1.9) 5 (0.6) 6 (1.2) 2 (1.9)
CNS 0 (0.0) 5 (1.1) 5 (1.0) 0 (0.0)
Others 0 (0.0) 7 (1.6) 7 (1.4) 0 (0.0)
Table 3. Etiologic microorganisms
CNS, coagulase negative staphylococcus.
Comparison between E. coli and K. Pnuemoniase (
� p<0.05). Comparison between 2000 and 2004 yr (*p<0.05). 
AP, ampicillin; SAM, ampicillin/sulbactam; GM, gentamycin; AK, amikacin; TOB, tobramycin; CIP, ciprofloxacin; LFX, levofloxcin; SPT, trimethoprim/sul-
famethoxazole.
AP SAM AK GM TOB SPT LFX CIP
Antibiotic sensitivity of E.coli and Klebsiella pneumoniae
E. coli 27.2 77.1 92.1 75.5
� 83.7 79.0 67.4 44.7
�
K. pnuemoniae 43.2 63.5 98.1 97.2
� 97.3 88.3 66.7 85.6
�
Antibiotics sensitivity of Gram (-) organisms between 2000 and 2004
2000 yr 38.5* 79.3 91.7 83.1* 85.3 80.2 67.5 59.0*
2004 yr 18.9* 74.4 95.4 72.1* 79.1 76.7 65.5 38.1*
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and TMP/SMX. In comparison with E. coli, K. pneumoniae
was found to be more susceptible to TMP/SMX and gen-
tamicin (p<0.05).
Reviewing the change of the antibiotic sensitivity of Gram
negitive bacteria from 2000 to 2004 yr, all the sensitivity to
ampicillin, gentamicin, and TMP/SMX were statistically
significantly reduced (p<0.05) (Table 4).
Curative urological procedures for complicated APN
For the treatment of complicated APN, urological proce-
dures were performed on 94 cases (9.2% of the entire APN
patients). Among them, the most frequent procedure was
urinary lithotripsy (42 cases, 44.7%) that consisted of extra-
corporeal shock wave lithotripsy (ESWL) (33 cases, 35.1%),
ureteoscopic stone removal (7 cases, 7.4%) and ureterolitho-
tomy (2 cases, 2.1%). And other procedures were followed
in the order of percutaneous nephrostomy (23 cases, 24.5%),
clean intermittent catheterization (14 cases, 14.9%), ure-
teroneocystostomy (10 cases, 10.6%), nephrectomy (5 cases,
5.3%) and percutaneous pus drainage (3 cases, 3.2%). Among
the cases performed percutaneous nephrostomy, 3 cases were
also performed other stone removal procedures. Among ne-
phrectomy cases, 4 cases were nonfunctioning atrophic kid-
ney, and the other was emphysematous pyelonephritis (EPN). 
DISCUSSION
UTI is bacterial infection that can be encountered frequently
in clinics, and APN is the most severe form of UTI. Depend-
ing on reports, the ratio of male to female varies from 1:7 to
1:13.1 (8-10), and in our study, similarly, it was 1:7.7, and
found to be substantially more prevalent in females. In females,
the prevalent ages were shown to be the 20s and 30s (38.6%
in our study), which is in agreement with other Korean re-
ports that it was prevalent in childbearing ages (8-10). Numer-
ous studies have been reported that in young women who
are sexually active, and using a diaphragm or spermicide
recurrent UTI could occurs (11). In addition, in our study,
the proportion of female cases older than 60 yr is 23.7%,
which is higher than previous studies reported in Korea. It
is thought that the increase of the diseases such as DM and
cerebral vascular disease due to the aging society and the
westernization of eating habit contributed to occurrence of
UTI.
In our study, the cases that bacteria had been isolated in
urine culture were found to be 505 patients (49.1%), which
is similar to the proportion of 53.4% reported by Sohn et al
in the 1990s (8). It is considered that the reasons of low rates
of the positive culture rate in such manners are that many
patients have taken antibiotics without prescription and while
being treated at private clinics previously, with antibiotics
as well. 
As for causative microorganisms, E. coli accounted for 84.3%,
and in agreement with previous reports, which turned out
markedly prevalent (8-10). Among isolated microorganisms,
the important point to which attentions have to be paid is
that only in the cases with risk factors such as neurogenic
bladder, kidney transplantation, urethral stricture, Pseudomonas
was cultured, and males were 80%, which was prevalent.
In our study, the antibiotic sensitivity test for ampicillin
to E. coli to was 27.7%, while 77.1% for ampicillin/sulbac-
tam, 79.0% for ciprofloxacin, 44.7% for TMP/SMX, 92.1%
for amikacin, and 77.1% for gentamicin 77.1%. In other
countries, it has been reported that antibiotic sensitivity for
TMP/SMX was 67-83.2%, 78-98.1% for ciprofloxacin and
25-82.3% for ampicillin (12-14). In Korea, according to Min
et. Al. they have reported that antibiotic sensitivity for ampi-
cillin was 13.2%, to TMP/SMX 44.7%, to ciprofloxacin
86.5%, and to amikacin 98.3% (10). According to our study
and previous studies reported in Korea, we found that the
antibiotic resistance of ampicillin and TMP/SMX is higher
than that of western countries.
Sepsis is a lethal sequela to APN patients, it has been re-
ported to be associated in approximately 7.4-22.6% (8), and
in our study, and it was shown to be 10.1%. In the cases awwo-
ciated with sepsis, high mortaility and seve clinical symp-
toms were accompanied (3, 4). In our study, similarly, in the
cases that bacteria were isolated in blood culture, the dura-
tion of flank pain was significantly longer than other cases.
In mild APN, Infectious Diseases Society of America (IDSA)
recommends an oral fluoroquinolone for empirical therapy.
If the organism is known to be susceptible, oral TMP/SMX
provides an alternative (15). If a patient at the time of pre-
sentation is sufficiently ill to require hospitalization (high
fever, high white blood cell count, vomiting, dehydration,
or evidence of sepsis) or fails to improve during an initial
outpatient treatment period, intravenous fluoroquinolone,
an aminoglycoside with or without ampicillin, or an extend-
edspectrum cephalosporin with or without an aminoglyco-
side are recommended (15). Concerning the duration of treat-
ment, the regimen of intravenous injection for 7 days and
subsequently oral administration for 1 week or 2 weeks are
recommended (16). In addition, Talan et al. (17) recommend-
ed the regimen of oral fluoroquinolone for 7 days or TMP/
SMX for 14 days. They also reported that bacteriologic cure
rates were 99% for the ciprofloxacin regimen and 89% for
the TMP/SMX regimen. However, as shown in our study,
the efficacy of the single ampicillin or TMP/SMX as the first-
line treatment is very low. In our study, ciprofloxacin showed
79.1% sensitivity against E. coli, and 88.3 % against K. pneu-
moniae, which tells it can be recommended as the first-line
oral therapy.
In Korea the proportion of complicated APN has been re-
ported to be approximately 21.1-37.8% (8-10), and in our
study, it is shown 32.7%. And in male it was higher than in
females. Finkelstein et al. (18) have reported that in compli-cated APN, the longer time was required for the ameliora-
tion of clinical symptoms, and such result was validated in
our study. These patients are also at increased risk for morbid-
ity such as bacteremia and sepsis, perinephric abscess, and
renal deterioration. Therefore, special attention is required,
which includes obtaining culture data and urinary tract imag-
ing, assessing renal function, and providing culture-specific
antimicrobial therapy. More specific medical or surgical thera-
py and urinary tract drainage may be required when neces-
sary (19).
In our study population, complicated factors such as struc-
tural or functional disorders were in the order of urinary tract
stone disease, vesicoureteral reflux, neurogenic bladder, ureter-
al obstruction, and benign prostate hyperplasia. In addition,
among 335 complicated APN patients, 94 patients received
the curative urologic procedures. To treat urinary tract stones,
ESWL, ureteroscopic stone removal or other lithotripsy were
performed in 42 cases, and in hydronephrosis due to ureter-
al obstruction, to preserve renal function and to diverse uri-
nary flow, percutaneous nephrostomy was performed in 23
cases. 
Most of the complicated APN patients who didn’t receive
surgical treatment were DM patients. And the others were
the diseases that were impossible to operate (e.g., nephrocalsi-
nosis, medullary sponge kidney, polycystic kidney), sponta-
neous expelled urinary stone disease, low-grade VUR, void-
ing dysfunction managed by medical therapy (alpha adren-
ergic blocking agents, anticholinergics, or cholinergic agents),
and so on. But physicians should closely follow up these pa-
tients to prevent recurrent infection.
As systemic diseases, DM has been reported to act as the
most important factor (8-10). In our study, DM was 29.3%
of complicated APN, which was most common. Several pos-
sible interactions occur between DM and UTI. Factors that
may predispose diabetics to complicated infections include
autonomic neuropathy leading to poor bladder emptying
and urinary stasis, microangiopathy, leukocyte dysfunction,
and frequent urinary tract instrumentation (20). The preva-
lence of bacteriuria is twice higher than the nondiabetics and
asymptomatic bacteriuria in diabetes frequently progresses
to symptomatic and upper UTIs, so it should be treated. In
addition, APN in DM patients is 5 times more frequent than
the nondiabetics (21) and can lead to serious complications
like septic shock, EPN, renal and perirenal abscess, and pap-
illary necrosis (22). Especially, EPN is life-threatening acute
necrotizing parenchymal and perirenal infection. It is required
immediate nephrectomy with glycemic control measures
and antibiotic administration is crucial. In inoperable cases,
percutaneous drainage can be an effective treatment option.
Therefore diabetics with febrile UTI should undergo urinary
tract imaging. Renal ultrasound should be performed if ob-
struction is suspected, whereas a computed tomography (CT)
scan is the imaging modality of choice to evaluate for renal
abscess, EPN, and other complications of UTI.
Upper urinary tract obstruction, whether primary or sec-
ondary, due to infravesical obstruction (e.g. prostatic diseases,
neurogenic bladder), can lead to highly elevated intrapelvic
pressure allowing intrarenal reflux of infected urine. In these
patients, instant drainage of the obstruction is mandatory as
is the immediate institution of broad-spectrum antimicrobial
treatment. If proper therapy is delayed, the infection might
progress to pyonephrosis, renal abscess or urosepsis that still
has a high mortality (23). To prevent these complications, a
routine ultrasound examination of the kidneys should be per-
formed during each episode of febrile UTI.
Infection due to indwelling catheters, cystoscopy, double
J-stent insertion or other urologic manipulation was detect-
ed in 8 cases. Naber et al. recommended preventive antibi-
otics for highly risk patients (poor systemic performance, DM
and other metabolic abnormality, immunosuppressive drug,
patients with artificial cardiac valvular replacement) while
performing cystoscopy, ureteroscopy, percutenous nephros-
tomy, and ESWL (6). Recommended antibiotic agents are
fluroquinolone, aminopenicillin/beta-lactamase inhibitor,
and second-generationed cephalosporin. In addition, in the
case with an indwelling catheter in the bladder, the possibil-
ity of bacteriuria is increased daily by 3-10%, and thus after
one month, bacteriuria is detected in most cases (24). Most
cases are asymptomatic, however, sepsis may be associated
in less than 5%, and thus if indwelling catheters are required,
to prevent the development of bacteriuria, it is required to
maintain a closed system, and clinicians should make efforts
to remove the catheter as early as possible (25, 26).
One third of APN is complicated APN, and over 60% of
its origin is urological diseases. In addition, for its treatment,
appropriate urological procedures are required. Most of all,
if fever and costovertebral angle tenderness sustain over 4
days, radiologic studies will be performed immediately, and
then proper surgical procedure should be performed. The
portion of the cases that bacteria were isolated in urine cul-
ture were 49.1%, which is speculated due to the result of
overusing antibiotics without prescription prior to admis-
sion. In addition, in APN, sepsis is associated in 10.1%, and
resistance to antibiotics shows a trend on the rise, hence, clin-
ical attentions are required. Particularly, antibiotics resistance
to ampicillin and TMP/SMX is high and the sensitivity is
on the decrease with the time, therefore, it is thought that
the reconsideration of their selection as first-line drugs is re-
quired.
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